GALDERMA GROUP NGALDERMA GROUP NGALDERMA GROUP N

GALDERMA GROUP N

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪20.27 B‬CHF
−0.05CHF
‪−51.40 M‬CHF
‪3.67 B‬CHF
‪92.05 M‬
Beta (1Y)
0.22
Employees (FY)
‪6.54 K‬
Change (1Y)
+190 +2.99%
Revenue / Employee (1Y)
‪665.65 K‬CHF
Net income / Employee (1Y)
‪−9.33 K‬CHF

About GALDERMA GROUP N


CEO
Flemming Ørnskov
Headquarters
Zug
Founded
1981
ISIN
CH1335392721
FIGI
BBG01LYFLBQ5
Galderma Group AG engages in the provision of science-based premium dermatology solutions. The firm is also involved in delivering a synergistic portfolio of flagship brands spanning the full spectrum of the fast-growing self-care dermatology market. The company was founded in 1981 and is headquartered in Zug, Switzerland.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of GALD is 85.18 CHF — it has decreased by −0.19% in the past 24 hours. Watch GALDERMA GROUP N stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SIX exchange GALDERMA GROUP N stocks are traded under the ticker GALD.
GALD stock has risen by 1.03% compared to the previous week, the month change is a 7.14% rise, over the last year GALDERMA GROUP N has showed a 39.64% increase.
We've gathered analysts' opinions on GALDERMA GROUP N future price: according to them, GALD price has a max estimate of 105.89 CHF and a min estimate of 79.89 CHF. Watch GALD chart and read a more detailed GALDERMA GROUP N stock forecast: see what analysts think of GALDERMA GROUP N and suggest that you do with its stocks.
GALD reached its all-time high on Nov 12, 2024 with the price of 86.19 CHF, and its all-time low was 60.00 CHF and was reached on Mar 22, 2024. View more price dynamics on GALD chart.
See other stocks reaching their highest and lowest prices.
GALD stock is 1.44% volatile and has beta coefficient of 0.22. Track GALDERMA GROUP N stock price on the chart and check out the list of the most volatile stocks — is GALDERMA GROUP N there?
Today GALDERMA GROUP N has the market capitalization of ‪20.27 B‬, it has increased by 2.05% over the last week.
Yes, you can track GALDERMA GROUP N financials in yearly and quarterly reports right on TradingView.
GALDERMA GROUP N is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
GALD earnings for the last half-year are 0.79 CHF per share, whereas the estimation was 0.90 CHF, resulting in a −12.00% surprise. The estimated earnings for the next half-year are 0.80 CHF per share. See more details about GALDERMA GROUP N earnings.
GALDERMA GROUP N revenue for the last half-year amounts to ‪1.98 B‬ CHF, despite the estimated figure of ‪1.98 B‬ CHF. In the next half-year revenue is expected to reach ‪1.97 B‬ CHF.
GALD net income for the last half-year is ‪41.81 M‬ CHF, while the previous report showed ‪−54.18 M‬ CHF of net income which accounts for 177.17% change. Track more GALDERMA GROUP N financial stats to get the full picture.
No, GALD doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 19, 2024, the company has ‪6.54 K‬ employees. See our rating of the largest employees — is GALDERMA GROUP N on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GALDERMA GROUP N EBITDA is ‪780.58 M‬ CHF, and current EBITDA margin is 20.89%. See more stats in GALDERMA GROUP N financial statements.
Like other stocks, GALD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GALDERMA GROUP N stock right from TradingView charts — choose your broker and connect to your account.